Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela

Clinics in Dermatology

Volumn 14, Issue 5, 1996, Pages 479-487

  Convit, Jacinto ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LEISHMANIA VACCINE;

HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; INFECTION PREVENTION; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS; VACCINATION; VENEZUELA;

EID: 0030248690     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00042-9     Document Type: Article

References (15)

1. 1. Ulrich M, Rodríguez V, Centeno M, et al. Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy. Clin Exp Immunol 1995;100:54-8.
2. 2. Lainson R, Shaw JJ. Leishmaniasis of the New World: Taxonomic problems. Br Med Bull 1972;28:44-8.
3. 3. Convit J, Pinardi ME. Cutaneous Leishmaniasis. The clinical and immunopathological spectrum in South America. Ciba Found Symp 1974;20:159-69.
4. 4. Convit J, Ulrich M, Fernández CT et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:444-8.
5. 5. Convit J, Lapenta P. Sobre un caso de leishmaniasis tegumentaria de forma diseminada. Rev Policlin Caracas 1948;17:153-8.
6. 6. Convit J: Leprosy and Leishmaniasis. Similar clinical-immunological-pathological models. Ethiop Med J 1974; 12:187-95.
7. 7. Sánchez M, Cáceres-Dittmar G, Oriol O, et al.Epidermal langerhans cells dendritic epidermal T cells in murine cutaneous leishmaniasis. Immunocytochemical Study. Acta Microsc 1993;2:180-7.
8. 8. Cáceres-Dittmar G, Tapia FJ, Sánchez M, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993;91:500-5.
9. 9. Convit J, Castellanos PL, Rondón AJ, et al. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet 2:1987;401-5.
10. 10. Convit J, Castellanos PL, Ulrich M, et al. Immunotherapy of localized, intermediate and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 1989;160:104-15.
11. 11. Tapia FJ, Cáceres-Dittmar G, Sánchez MA, et al. The cutaneous lesion in American leishmaniasis: Leukocyte subsets, cellular interaction and cytokine production. Biol Res 1993;26:239-47.
12. 12. Hernández D, Rodríguez N, Martínez C, et al. Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg 1993;87:627-8.
13. 13. Bloom BR, Mehra VL, Melancou-Kaplan J, et al. Mechanisms of immunological responsiveness in the spectra of leprosy and leishmaniasis. In: "Host defenses and Immunomodulation to Intracellular Pathogens." Eisenstein TK, Bullock WE, and Hanna N, eds. New York: Plenum, 1988, pp 263-278.
14. 14. Convit J, Pinardi ME, Rodríguez Ochoa G, et al. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin Exp Immunol 1974;17:261-5.
15. 15. Pessoa, S.B. Classificacao das leishmanioses e das especies do genero Leishmania. Arg. Fac. Hig. S. Paulo 1961;26:41-50.